BR112016001774A2 - métodos de preparação de ribosídeo de nicotinamida e seus derivados - Google Patents
métodos de preparação de ribosídeo de nicotinamida e seus derivadosInfo
- Publication number
- BR112016001774A2 BR112016001774A2 BR112016001774A BR112016001774A BR112016001774A2 BR 112016001774 A2 BR112016001774 A2 BR 112016001774A2 BR 112016001774 A BR112016001774 A BR 112016001774A BR 112016001774 A BR112016001774 A BR 112016001774A BR 112016001774 A2 BR112016001774 A2 BR 112016001774A2
- Authority
- BR
- Brazil
- Prior art keywords
- substituted
- unsubstituted
- derivatives
- nicotinamide riboside
- preparation methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/048—Pyridine radicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
a invenção refere-se a métodos de preparação do ribosídeo de nicotinamida e seus derivados. por um lado, a invenção se refere a um método de preparação de um composto de fórmula (i), onde n é 0 ou 1; m é 0 ou 1; y é o ou s; r1 é selecionado de h, alquil substituído ou não substituído, alqueno substituído ou não substituído, alquenil substituído ou não substituído, aril substituído ou não substituído, amino primário ou secundário substituído ou não substituído e azido substituído ou não substituído; r2-r5, que podem ser iguais ou diferentes, são cada um selecionado independentemente a partir de h, alquil substituído ou não substituído, alquenil substituído ou não substituído, alquenil substituído ou não substituído e aril substituído ou não substituído; e x é um ânion, selecionado a partir de um ânion de um ácido carboxílico substituído ou não substituído, um haleto, um sulfonato substituído ou não substituído, um fosfato substituído ou não substituído, um sulfato substituído ou não substituído, um carbonato substituído ou não substituído e um carbamato substituído ou não substituído.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1313465.5A GB201313465D0 (en) | 2013-07-29 | 2013-07-29 | Methods of preparing nicotinamide riboside and derivatives thereof |
GB1313465.5 | 2013-07-29 | ||
PCT/EP2014/065971 WO2015014722A1 (en) | 2013-07-29 | 2014-07-24 | Methods of preparing nicotinamide riboside and derivatives thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112016001774A2 true BR112016001774A2 (pt) | 2017-08-01 |
BR112016001774A8 BR112016001774A8 (pt) | 2020-01-21 |
BR112016001774B1 BR112016001774B1 (pt) | 2021-06-22 |
Family
ID=49167061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016001774-9A BR112016001774B1 (pt) | 2013-07-29 | 2014-07-24 | Método para o preparo de um composto |
Country Status (14)
Country | Link |
---|---|
US (5) | US10000519B2 (pt) |
EP (2) | EP3321274A1 (pt) |
JP (1) | JP6208352B2 (pt) |
KR (2) | KR102303966B1 (pt) |
CN (2) | CN108707174A (pt) |
AU (4) | AU2014298629B2 (pt) |
BR (1) | BR112016001774B1 (pt) |
CA (2) | CA3192957A1 (pt) |
ES (1) | ES2652654T3 (pt) |
GB (1) | GB201313465D0 (pt) |
HK (2) | HK1218918A1 (pt) |
MX (1) | MX349969B (pt) |
WO (1) | WO2015014722A1 (pt) |
ZA (1) | ZA201802315B (pt) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201313465D0 (en) | 2013-07-29 | 2013-09-11 | Queens University Of The Belfast | Methods of preparing nicotinamide riboside and derivatives thereof |
CA2950727A1 (en) * | 2014-06-02 | 2015-12-10 | Glaxosmithkline Intellectual Property (No.2) Limited | Preparation and use of crystalline beta-d-nicotinamide riboside |
WO2015186114A1 (en) * | 2014-06-06 | 2015-12-10 | Glaxosmithkline Intellectual Property (No.2) Limited | Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof |
CN106715454B (zh) * | 2014-07-24 | 2020-06-16 | 格雷斯公司 | 烟酰胺核苷的结晶形式 |
BR112017019409A2 (pt) * | 2015-03-09 | 2018-04-24 | Grace W R & Co | forma cristalina de ribosídeo de nicotinamida |
MX2017011851A (es) * | 2015-03-16 | 2018-04-11 | Chromadex Inc | Composiciones de acido nicotinico ribosido o de nicotinamida ribosido, derivados reducidos de los mismos, y su uso. |
US10392414B2 (en) | 2015-07-15 | 2019-08-27 | Cornell University | Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives |
EP3331894B1 (en) | 2015-08-05 | 2021-02-17 | Metro International Biotech, LLC | Nicotinamide mononucleotide derivatives and their uses |
GB2542881B (en) | 2015-10-02 | 2020-01-01 | Carr Andrew | Crystal forms of ß-nicotinamide mononucleotide |
WO2017079195A1 (en) * | 2015-11-02 | 2017-05-11 | Mitobridge, Inc. | Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases |
US11248018B2 (en) | 2016-02-23 | 2022-02-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Process for preparation of nicotinamide riboside (NR) and cosmetic composition comprising (NR and a phosphate-binding agent |
EP3429354A4 (en) | 2016-03-16 | 2020-03-25 | Chromadex Inc. | B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF AND METHOD FOR THE PRODUCTION THEREOF |
NZ747693A (en) | 2016-04-20 | 2023-07-28 | Chromadex Inc | Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as nad+increasing precursors |
WO2017218580A1 (en) | 2016-06-14 | 2017-12-21 | Rejuvenation Therapeutics Corporation | Synthetic methods for the preparation of nicotinamide riboside and related compounds |
GB2553001A (en) * | 2016-08-19 | 2018-02-21 | The Queen's Univ Of Belfast | Lactone intermediates of nicotinamide riboside and nicotinate riboside |
US9975915B1 (en) * | 2016-11-11 | 2018-05-22 | The Queen's University Of Belfast | Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof |
CA3044814A1 (en) | 2016-11-29 | 2018-06-07 | Charles M. Brenner | Use of nad precursors for improving maternal health and/or offspring health |
US11071747B2 (en) | 2016-11-29 | 2021-07-27 | University Of Iowa Research Foundation | Use of NAD precursors for breast enhancement |
US11286274B2 (en) | 2017-06-19 | 2022-03-29 | Mitopower Llc | Nicotinamide riboside derivatives and their uses |
WO2019006262A1 (en) * | 2017-06-30 | 2019-01-03 | Elysium Health, Inc. | METHODS OF SYNTHESIZING NICOTINAMIDE RIBOSIDE |
CN112020363A (zh) | 2017-12-22 | 2020-12-01 | 益力舒健康公司 | 烟酰胺核苷氯化物的结晶形式 |
WO2019122084A1 (en) | 2017-12-22 | 2019-06-27 | Stemtek Therapeutics, S.L. | Process for the preparation of nicotinamide riboside chloride derivatives |
US11180521B2 (en) | 2018-01-30 | 2021-11-23 | Metro International Biotech, Llc | Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof |
CN110283221A (zh) * | 2018-03-19 | 2019-09-27 | 药源药物化学(上海)有限公司 | 杂环化合物的制备和纯化方法 |
CN110452277A (zh) * | 2018-05-07 | 2019-11-15 | 明特奇点医疗科技(成都)有限公司 | 一种烟酰胺核糖的制备方法 |
CN113490675A (zh) * | 2018-05-22 | 2021-10-08 | 江普斯塔特生育有限公司 | 作为抗衰老剂的烟酸核苷的氨基酸盐 |
CN108774278A (zh) * | 2018-09-10 | 2018-11-09 | 张洪喜 | 一种制备尼克酰胺核苷盐的方法 |
KR102060374B1 (ko) * | 2018-12-14 | 2019-12-30 | 주식회사 휴메딕스 | 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체 |
EP3897666A2 (en) | 2018-12-17 | 2021-10-27 | Mitopower LLC | Nicotinyl riboside compounds and their uses |
US11939348B2 (en) | 2019-03-22 | 2024-03-26 | Metro International Biotech, Llc | Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide |
US10618927B1 (en) | 2019-03-22 | 2020-04-14 | Metro International Biotech, Llc | Compositions and methods for modulation of nicotinamide adenine dinucleotide |
US20220324899A1 (en) * | 2019-08-14 | 2022-10-13 | Metro International Biotech, Llc | Compounds and compositions for differential modulation of nicotinamide adenine dinucleotide |
CN110642897B (zh) * | 2019-09-27 | 2021-04-06 | 武汉一若生物材料有限公司 | 一种β-烟酰胺核糖氯化物的制备方法 |
CN110658224B (zh) * | 2019-10-15 | 2022-11-22 | 中国中医科学院中药研究所 | 一种氢核磁定量分析技术测定nmn绝对含量的方法 |
CN111153953A (zh) * | 2020-01-07 | 2020-05-15 | 杭州洁汉化工有限公司 | 一种烟酰胺核糖氯化物的高效合成方法 |
CN111454311B (zh) * | 2020-04-03 | 2021-10-19 | 深圳市迪克曼科技开发有限公司 | 烟酰胺核糖的有机酸盐及其组合物与制备方法 |
CN111647032B (zh) * | 2020-06-29 | 2023-02-24 | 上海舒泽生物科技研究所 | 一种β-烟酰胺单核苷酸的合成方法 |
CN111848710A (zh) * | 2020-08-20 | 2020-10-30 | 深圳市迪克曼科技开发有限公司 | 烟酰胺核糖及其还原态、盐的制备方法 |
US20230271995A1 (en) * | 2020-09-15 | 2023-08-31 | Societe Des Produits Nestle S.A. | Methods for producing dihydronicotinamide riboside from nicotinamide riboside chloride |
CN112851730B (zh) * | 2021-01-08 | 2023-02-21 | 厦门瑞林药业有限公司 | 一种nmn中间体nr氯化物合成方法 |
JP2024517260A (ja) | 2021-05-04 | 2024-04-19 | ボーハン アンド カンパニー エーエス | ニコチンアミドリボシドクロリド(nrcl)の合成プロセス |
WO2022251491A1 (en) | 2021-05-27 | 2022-12-01 | Metro International Biotech, Llc | Crystalline solids of nicotinic acid mononucleotide and esters thereof and methods of making and use |
WO2023166160A1 (en) | 2022-03-04 | 2023-09-07 | Bohan & Co As. | Process for synthesis of 1,4-dihydronicotinamide riboside (nrh) from nicotinamide-beta-riboside triacetate chloride (nra-cl) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0540263A1 (en) * | 1991-10-23 | 1993-05-05 | Cancer Research Campaign Technology Limited | Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form |
US6689760B1 (en) * | 2000-07-10 | 2004-02-10 | Enzrel Inc. | Anti-mycobacterial compositions |
EP3369738B1 (en) * | 2005-11-18 | 2020-05-20 | Cornell Research Foundation, Inc. | Method for making nicotinoyl ribosides and nicotinamide beta-riboside |
US9603862B2 (en) | 2009-12-14 | 2017-03-28 | Cornell University | Activation and activators of SIRT5 |
GB201313465D0 (en) | 2013-07-29 | 2013-09-11 | Queens University Of The Belfast | Methods of preparing nicotinamide riboside and derivatives thereof |
-
2013
- 2013-07-29 GB GBGB1313465.5A patent/GB201313465D0/en not_active Ceased
-
2014
- 2014-07-24 EP EP17191481.5A patent/EP3321274A1/en active Pending
- 2014-07-24 CA CA3192957A patent/CA3192957A1/en active Pending
- 2014-07-24 BR BR112016001774-9A patent/BR112016001774B1/pt active IP Right Grant
- 2014-07-24 JP JP2016530446A patent/JP6208352B2/ja active Active
- 2014-07-24 KR KR1020167005556A patent/KR102303966B1/ko active IP Right Grant
- 2014-07-24 US US14/908,831 patent/US10000519B2/en active Active
- 2014-07-24 AU AU2014298629A patent/AU2014298629B2/en active Active
- 2014-07-24 EP EP14744082.0A patent/EP3027635B1/en active Active
- 2014-07-24 MX MX2016001211A patent/MX349969B/es active IP Right Grant
- 2014-07-24 CA CA2918955A patent/CA2918955C/en active Active
- 2014-07-24 CN CN201810413840.9A patent/CN108707174A/zh active Pending
- 2014-07-24 KR KR1020217009552A patent/KR102414886B1/ko active IP Right Grant
- 2014-07-24 CN CN201480043268.1A patent/CN105636973B/zh active Active
- 2014-07-24 WO PCT/EP2014/065971 patent/WO2015014722A1/en active Application Filing
- 2014-07-24 ES ES14744082.0T patent/ES2652654T3/es active Active
-
2016
- 2016-06-14 HK HK16106843.8A patent/HK1218918A1/zh unknown
-
2018
- 2018-02-27 US US15/905,922 patent/US10815262B2/en active Active
- 2018-04-09 ZA ZA2018/02315A patent/ZA201802315B/en unknown
- 2018-08-01 AU AU2018211238A patent/AU2018211238A1/en not_active Abandoned
- 2018-11-06 HK HK18114160.5A patent/HK1255037A1/zh unknown
-
2020
- 2020-02-21 AU AU2020201254A patent/AU2020201254B2/en active Active
- 2020-05-29 US US16/886,985 patent/US11584770B2/en active Active
-
2022
- 2022-05-04 US US17/736,834 patent/US11981698B2/en active Active
- 2022-05-12 AU AU2022203196A patent/AU2022203196B2/en active Active
-
2023
- 2023-04-26 US US18/307,733 patent/US20240101588A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016001774A2 (pt) | métodos de preparação de ribosídeo de nicotinamida e seus derivados | |
BR112017025969A2 (pt) | métodos, e métodos para produzir monofosfato de tiaminila, de piridoxila, de adenosila, ou um sal dos mesmos | |
CY1124537T1 (el) | Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα | |
CY1118435T1 (el) | Παραγωγο μορφολινο νουκλεϊνικου οξεος | |
EA201591503A1 (ru) | Производные нафтиридина, полезные в качестве антагонистов альфа-v-бета-6 интегрина | |
MY176803A (en) | Polymorph of syk inhibitors | |
CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
EA201500875A1 (ru) | СОЛИ ПРОИЗВОДНЫХ 2-АМИНО-1-ГИДРОКСИЭТИЛ-8-ГИДРОКСИХИНОЛИН-2-(1Н)-ОНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ М3 | |
MX2015016513A (es) | Bisulfato del inhibidor de la janus quinasa (jak) y metodo de preparacion para el mismo. | |
MX2017014661A (es) | Proceso para la preparacion de triazinas. | |
PH12014501711A1 (en) | Benzyl sulfonamide derivatives useful as mogat-2 inhibitors | |
BR112015019437A2 (pt) | complexo de bis(2-indenil) metaloceno | |
BR112021026899A2 (pt) | Compostos heterocíclicos | |
MX2018003047A (es) | Metodo para producir sales de biguanida y s-triazinas. | |
BR112018001255A2 (pt) | composto direcionado à il-23a e fator de ativação de células b (baff) e seus usos | |
WO2016142819A3 (en) | Novel process for the preparation of ranolazine | |
TR201819440T4 (tr) | Yüklü çapraz bağlayıcıların hazırlanmasına yönelik yöntemler. | |
CY1115372T1 (el) | Συνθεσεις δεσοξυχολικου οξεος και αλατα αυτου | |
BR112015029589A2 (pt) | compostos de amônio quaternário e composições inibidoras de hidrato de gás | |
CY1114704T1 (el) | Κρυσταλλικη μορφη δ του αλατος αργινινης της περινδοπριλης, μεθοδος παρασκευης της και φαρμακευτικες συνθεσεις οι οποιες την περιεχουν | |
AR098397A1 (es) | Proceso de fluoración de compuestos | |
CL2018001961A1 (es) | Procedimiento de preparación de derivados de metil-penam (divisional solicitud 201602880) | |
MY186396A (en) | Xanthine derivative | |
CY1116826T1 (el) | Μεθοδος ενζυματικης συνθεσης toy (7s) 3,4-ιμεθοξυδικυκλο[4.2.0]οκτα- 1,3,5-τριενο-7-καρβοξυλικου οξεος και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης | |
EA201400882A1 (ru) | Способ стереоселективного синтеза 9-гидрокси-5-оксо-1,4-диазаспиро[5.5]ундеканов, содержащих защитные группы в 1,4-положениях |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/07/2014, OBSERVADAS AS CONDICOES LEGAIS. |